Drug Profile
Simotaxel
Alternative Names: MST-997; TL-909Latest Information Update: 08 Mar 2016
Price :
$50
*
At a glance
- Originator Taxolog
- Class Antineoplastics; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 18 Oct 2004 Data presented at the 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR-2004) have been added to the Cancer pharmacodynamics section
- 02 Aug 2004 A preclinical study has been added to the Cancer pharmacodynamics section